Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
0.00%
OPERATING MARGIN AVG 15Y
-4.54%
OPERATING MARGIN AVG 20Y
-9.02%
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
+100.00%
CURRENT VS 20Y AVG
+100.00%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 715 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
GT Biopharma, Inc.
Market Cap
$8.01M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$7.97M
Operating Margin
N/A
TTM Avg
-193400.24%
3Y Avg
-134850.20%
5Y Avg
-97032.76%
Market Cap
$7.95M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$8.14M
Operating Margin
0.00%
TTM Avg
-476.50%
3Y Avg
-901.45%
5Y Avg
-600.97%
Market Cap
$7.83M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$7.76M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$8.32M
Operating Margin
-347.91%
TTM Avg
-190.91%
3Y Avg
-98.06%
5Y Avg
-98.06%
Market Cap
$8.47M
Operating Margin
-70.47%
TTM Avg
-55.55%
3Y Avg
-42.46%
5Y Avg
-30.21%
Market Cap
$7.31M
Operating Margin
-0.52%
TTM Avg
-80.25%
3Y Avg
-135.01%
5Y Avg
-301.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | $8.01M | 0.00% | 0.00% | 0.00% | 0.00% |
| HeartSciences Inc. (HSCS)vs › | $7.97M | N/A | -193400.24% | -134850.20% | -97032.76% |
| ENDRA Life Sciences Inc. (NDRA)vs › | $7.95M | 0.00% | 0.00% | 0.00% | 0.00% |
| Aprea Therapeutics, Inc. (APRE)vs › | $8.14M | 0.00% | -476.50% | -901.45% | -600.97% |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.83M | 0.00% | 0.00% | 0.00% | 0.00% |
| Quince Therapeutics, Inc. (QNCX)vs › | $7.76M | 0.00% | 0.00% | 0.00% | 0.00% |
| DataMEDS AI, Inc. (MEDS)vs › | $8.32M | -347.91% | -190.91% | -98.06% | -98.06% |
| Healthcare Triangle, Inc. (HCTI)vs › | $8.47M | -70.47% | -55.55% | -42.46% | -30.21% |
| InMed Pharmaceuticals Inc. (INM)vs › | $7.31M | -0.52% | -80.25% | -135.01% | -301.00% |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.24M | 0.00% | 0.00% | -19.45% | -19.45% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | -92566.67% |
| 2015-06-30 | -7155.00% |
| 2015-03-31 | -25871.43% |
| 2014-12-31 | -4975.76% |
| 2014-09-30 | -18300.00% |
| 2014-06-30 | -416.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | -565.85% |
| 2013-09-30 | -76.50% |
| 2013-06-30 | -132.14% |
| 2013-03-31 | -394.32% |
| 2012-12-31 | -337.44% |
| 2012-09-30 | -1125.00% |
| 2012-06-30 | -103000.00% |
| 2012-03-31 | -39700.00% |
| 2011-12-31 | -34933.33% |
| 2011-09-30 | -27050.00% |
| 2011-06-30 | -48100.00% |
| 2011-03-31 | -9290.00% |
| 2010-12-31 | -4790.91% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 0.00% |
| 2009-12-31 | -5492.31% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | -617.14% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | 34.73% |
| 2008-09-30 | -135.24% |
| 2008-06-30 | 20.19% |
| 2008-03-31 | -32.92% |
| 2007-12-31 | -63.37% |
| 2007-09-30 | -15.12% |
| 2007-06-30 | 22.34% |
| 2007-03-31 | -32.49% |
| 2006-12-31 | -87.81% |
| 2006-09-30 | -24.67% |
| 2006-06-30 | -36.28% |
| 2006-03-31 | -38.33% |
| 2005-12-31 | -289.99% |
| 2005-09-30 | -63.91% |
| 2005-06-30 | -60.72% |
| 2005-03-31 | -40.10% |
| 2004-12-31 | -95.37% |
| 2004-09-30 | 15.09% |
| 2004-06-30 | -182.45% |
| 2004-03-31 | -78.31% |
| 2003-12-31 | -21.03% |
| 2003-09-30 | -25.00% |
| 2003-06-30 | -41.60% |
| 2003-03-31 | -28.05% |
| 2002-12-31 | -21.26% |
| 2002-09-30 | -69.48% |
